SCHEMBL1633905

SCHEMBL1633905

CC(C)Cn1cc(-c2cccc3cnc(Nc4ccc(S(N)(=O)=O)cc4)nc23)cn1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 1/20 0.49
CDK2 P24941 5/20 0.48
CDK1 P06493 5/20 0.48
CDK9 P50750 5/20 0.48
CCNT1 O60563 4/20 0.48
CCNB1 P14635 4/20 0.48
CCNE1 P24864 3/20 0.48
CCNB2 O95067 2/20 0.48
CCNE2 O96020 2/20 0.48
CDK5 Q00535 2/20 0.48
CDK5R1 Q15078 2/20 0.48
CCNB3 Q8WWL7 2/20 0.48
AXL P30530 4/20 0.46
TYRO3 Q06418 4/20 0.46
MERTK Q12866 4/20 0.46
IKBKB O14920 3/20 0.45
MAPK8 P45983 2/20 0.44
TTK P33981 1/20 0.44
PIK3CD O00329 1/20 0.44
AURKA O14965 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13498360 0.89 CCNT1 (0.52) JAK2CDK2CDK1CDK9CCNT1
SCHEMBL1633718 0.85 CDK2 (0.66) JAK2CDK2CDK1CDK9CCNT1
SCHEMBL1570569 0.82 CDK2 (0.48) CDK2CDK1CDK9CCNT1CCNB1
SCHEMBL1633220 0.82 MAP4K1 (0.51) CDK2CDK1CDK9CCNT1CCNB1
SCHEMBL1634357 0.80 AXL (0.43) JAK2CDK2CDK1CDK9CCNT1
SCHEMBL1631112 0.79 IKBKB (0.59) CDK2CDK1CDK9CCNT1CCNB1
SCHEMBL1633372 0.78 IKBKB (0.53) CDK2CDK1CDK9CCNT1CCNB1
SCHEMBL1633248 0.78 IKBKB (0.53) CDK2CDK1CDK9CCNT1CCNB1
SCHEMBL1632977 0.78 IKBKB (0.53) JAK2CDK2CDK1CDK9CCNT1
SCHEMBL1633475 0.77 MAPK10 (0.53) CDK2CDK1CDK9CCNT1CCNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed